Literature DB >> 1356125

IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells.

H Yssel1, R De Waal Malefyt, M G Roncarolo, J S Abrams, R Lahesmaa, H Spits, J E de Vries.   

Abstract

Murine IL-10 has been reported originally to be produced by the Th2 subset of CD4+ T cell clones. In this study, we demonstrate that human IL-10 is produced by Th0, Th1-, and Th2-like CD4+ T cell clones after both Ag-specific and polyclonal activation. In purified peripheral blood T cells, low, but significant, levels of IL-10 were found to be produced by the CD4+CD45RA+ population, whereas CD4+CD45RA- "memory" cells secreted 5- to 20-fold higher levels of IL-10. In addition, IL-10 was produced by activated CD8+ peripheral blood T cells. Optimal induction of IL-10 was observed after activation by specific Ag and by the combination of anti-CD3 mAb and the phorbol ester tetradecanoyl phorbol acetate, whereas the combination of calcium ionophore A23187 and 12-O-tetradecanoylphorbol-13-acetate acetate was a poor inducer of IL-10 production. Kinetic studies indicated that IL-10 was produced relatively late as compared with other cytokines. Maximal IL-10 mRNA expression in CD4+ T cell clones and purified peripheral blood T cells was obtained after 24 h, whereas maximal IL-10 protein synthesis occurred between 24 h and 48 h after activation. No differences were observed in the kinetics of IL-10 production among Th0, Th1-, and Th2-like subsets of CD4+ T cell clones. The results indicate a regulatory role for IL-10 in later phases of the immune response.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1356125

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  85 in total

Review 1.  Cytokines: past, present, and future.

Authors:  J J Oppenheim
Journal:  Int J Hematol       Date:  2001-07       Impact factor: 2.490

Review 2.  Toll-like receptors: molecular mechanisms of the mammalian immune response.

Authors:  H D Brightbill; R L Modlin
Journal:  Immunology       Date:  2000-09       Impact factor: 7.397

3.  Expression of L-selectin (CD62L) discriminates Th1- and Th2-like cytokine-producing memory CD4+ T cells.

Authors:  H Kanegane; Y Kasahara; Y Niida; A Yachie; S Sughii; K Takatsu; N Taniguchi; T Miyawaki
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

4.  Relationship between host survival and the type of immune response in different organs during disseminated candidiasis.

Authors:  Fei Cao; Jiawen Li; Xiaofeng Yan; Yanqing Wu; Demei Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

Review 5.  Glycogen synthase kinase 3: a point of convergence for the host inflammatory response.

Authors:  Huizhi Wang; Jonathan Brown; Michael Martin
Journal:  Cytokine       Date:  2010-11-23       Impact factor: 3.861

6.  Cytokine expression in squamous intraepithelial lesions of the uterine cervix: implications for the generation of local immunosuppression.

Authors:  S L Giannini; W Al-Saleh; H Piron; N Jacobs; J Doyen; J Boniver; P Delvenne
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

7.  Production of interleukin-10 by human bronchogenic carcinoma.

Authors:  D R Smith; S L Kunkel; M D Burdick; C A Wilke; M B Orringer; R I Whyte; R M Strieter
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

8.  High levels of circulating IL-10 in human malaria.

Authors:  F Peyron; N Burdin; P Ringwald; J P Vuillez; F Rousset; J Banchereau
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

9.  The capsular polysaccharide complex of Bacteroides fragilis induces cytokine production from human and murine phagocytic cells.

Authors:  F C Gibson; A O Tzianabos; A B Onderdonk
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

10.  Analysis of cytokine profiles in synovial T cell clones from chlamydial reactive arthritis patients: predominance of the Th1 subset.

Authors:  A K Simon; E Seipelt; P Wu; B Wenzel; J Braun; J Sieper
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.